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Introduction
Colorectal cancer (CRC) is the third most commonly diagnosed cancer 
in the United States with approximately 4.2% of the population being 
diagnosed with CRC during their lifetime(1,3,13). Since the 
implementation of screening colonoscopies, the rate of CRC  in 
patients over 50 has steadily declined over the past several years 
(12,13). Specifically, the incidence of CRC has decreased by 2.6% each 
year during the last 10 years with a 2.4% decline in the mortality rate 
each year (13). This likely corresponds to the early removal of benign 
polyps prior to malignant transformation. Despite this steady decline 
in incidence and mortality in patients over 50, estimates of new CRC 
diagnoses and mortality for 2018 remain staggering with upwards of 
140,250 patients diagnosed and  over 50,000 death(13).
Guidelines prior to 2018 recommended screening colonoscopies to 
begin at age 50 in patients without a family history of CRC(3). While 
there was decreased incidence and mortality as illustrated above, a 
new patient population was increasing in numbers, those under the 
age of 50. For this reason, The American Cancer Society recently 
changed their recommendation to begin screening colonoscopies at 
age 45 in patients without a family history. 
The National Institute of Health Surveillance, Epidemiology and End 
Results Program has shown an increase in CRC in patients under age 
50 by 1.7% annually from 1992 to 2013 and an increase of 5.1% per 
year from 2013 to 2015(13). There is limited data and studies about 
this patient population, their staging and mortality. Meyers et al. 
showed 53% of patients under age 50 were diagnosed with stage 3 or 
4 CRC compared to 41% of CRC patients over age 50 with stage 3 or 
4(9). Li et al. recently demonstrated no significant difference in 5-year 
survival rates between patients above and below age 40 (7). This study 
is aimed to review all patients diagnosed with CRC at a single 
institution from 1997 to 2017 with a focus on comparing incidence,  
stage at diagnosis and mortality  in patients over and under age 50.
. 
Methods
This is a retrospective review using electronic medical records from the 
McGlinn Cancer Institute between 1997 and  2017. Inclusion criteria 
involved patients older than age 18, a biopsy proven diagnosis of CRC and 
no known genetic predisposition to CRC. The data was then aggregated by 
age, gender, tumor location, stage and mortality over the past 20 years. Chi 
square and logtest analysis was used to determine significant trends 
between these metrics.
Results
From 1997 to 2017, 3188 patients were diagnosed with CRC, 245 patients 
(7.7%) below age 50 and 2943 (92.3%) above age 50. There was no 
significant change in incidence over 20 years for patients above or below 
age 50. CRC patients under age 50 were diagnosed at a higher stage when 
compared to patients above age 50 (P = 0.0002). Specifically, 71% of 
patients under age 50 were diagnosed at stage 2 or higher, whereas the 
stage at diagnosis for patients above age 50 was more evenly distributed 
with only 57% being diagnosed at stage 2 or higher. Despite the higher 
stage at diagnosis, younger patients were found to have a lower mortality 
rate but only statistically significant at stages 2 and 4. Patients under age 
50 diagnosed with stage 2 or stage 4 CRC had a significantly higher 5 year 
survival when compared with patients over age 50 diagnosed at the same 
stage (p<0.05).  No statistically significant difference was identified when 
evaluating gender or location of tumor between these two age groups.
Discussion
For patients below age 50, there is no change in incidence of CRC. Those 
diagnosed with CRC under age 50 were more likely to be diagnosed at a 
higher stage of CRC compared to patients diagnosed above age 50. 
Despite being diagnosed at high stages of CRC, those diagnosed 
specifically at stage 2 or 4 were found to have greater 5 year survival 
compared to patients above age 50. 
Based on our data, initiating screening colonoscopies at age 45 may 
downgrade the stage at diagnosis however, its effect on survival has yet 
to be determined. Further evaluation including risk factors for CRC at 
younger ages, effect of beginning screening colonoscopies at age 45 and 
differences in management between these groups are required.  
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